Delivery Order SPE2DB25D3012-SPE2DB25FXALL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,395.32 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Humalog 100 Unit/mL vials (10 mL). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,943.94 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10mL units), with an ultimate completion date of August 27, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Humalog 100 Unit/mL vials (10mL) with a ceiling value of $1,884.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10 mL) with a ceiling value of $1,472.06. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, issued on September 8, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,177.75 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML vials (10 ML) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.30 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) on August 21, 2025, with an ultimate completion date of August 22, 2025. This contract represents a firm fixed price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,267.94 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) under a firm fixed price contract. This award, announced on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) with a ceiling value of $1,130.64. The order, which was competitively awarded without set-aside designation, has a firm fixed price structure and an ultimate completion date of September 16, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, will serve as the place of performance for this pharmaceutical supply...
- This delivery order, valued at $1,025.32, awards AmerisourceBergen Drug Corp the supply of Humalog 100 Unit/mL vials (10 mL) for the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and was competitively awarded without set-aside provisions. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement to...
- The Defense Logistics Agency awarded a delivery order valued at $1,130.64 to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML vials (10 ml) on September 10, 2025, with completion scheduled for September 11, 2025. This competitive award with firm fixed pricing represents a small-value pharmaceutical procurement utilizing no set-aside designation. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and falls under the company's existing...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXALLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Humalog 100 Unit/mL vials (10 mL) with a ceiling value of $2,355.50. This is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and represents a pediatric/non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026 that provides global pharmaceutical support to military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling competitively awarded delivery orders for a diverse range of pharmaceutical products and medical supplies across multiple therapeutic domains. This Humalog order reflects the company's ongoing role in supporting military and federal healthcare supply chains through the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/24/25 |